Benkowitz Michael's Form 4 filing
United Therapeutics CorpUTHR · filed Nov 4, 2024
- Accession no.
- 0001415889-24-025975
- Filed
- Nov 4, 2024
- Trade date
- Nov 1, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.50M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Common Stock | MOption exerciseAcquired | +14,700 | $120.26 | +$1,767,822 | 14,700 | Indirect | |
| Nov 1, 2024 | Common Stock | SSaleDisposed | −200 | $370.65F2 | −$74,130 | 14,500 | Indirect | |
| Nov 1, 2024 | Common Stock | SSaleDisposed | −800 | $371.71F3 | −$297,368 | 13,700 | Indirect | |
| Nov 1, 2024 | Common Stock | SSaleDisposed | −1,200 | $373.05F4 | −$447,660 | 12,500 | Indirect | |
| Nov 1, 2024 | Common Stock | SSaleDisposed | −6,096 | $374.02F5 | −$2,280,025.92 | 6,404 | Indirect | |
| Nov 1, 2024 | Common Stock | SSaleDisposed | −3,501 | $375.06F6 | −$1,313,085.06 | 2,903 | Indirect | |
| Nov 1, 2024 | Common Stock | SSaleDisposed | −1,803 | $375.83F7 | −$677,621.49 | 1,100 | Indirect | |
| Nov 1, 2024 | Common Stock | SSaleDisposed | −1,000 | $376.94F8 | −$376,940 | 100 | Indirect | |
| Nov 1, 2024 | Common Stock | SSaleDisposed | −100 | $378.00 | −$37,800 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Common Stock | MOption exerciseDisposed | −14,700 | $0.00 | $0 | 4,500 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $370.38 to $370.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $371.41 to $372.2775. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $372.434 to $373.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $373.4616 to $374.4129. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $374.47 to $375.4685. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $375.4825 to $376.3012. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $376.5701 to $377.2793. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.